U.S. Contract Research Organization Market, By Service Typ, By Therapeutic Application, By Size of CROs

Description

The U.S. contract research organization (CROs) market is estimated to be valued at USD 19.44 Bn in 2024 and is expected to reach USD 43.61 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.2% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 19.44 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	12.20%	2031 Value Projection:	US$ 43.61 Bn

Figure 1.U.S. Contract Research Organization (CROs) Market Share (%), By Service Type, 2024

U.S. Contract Research Organization Market - IMG1

The U.S. Contract Research Organization (CROs) market has seen significant growth over the past decade, driven by increasing drug development activities and clinical trials outsourcing among pharmaceutical companies. A CRO provides various services like clinical trial management, data management, regulatory & medical affairs, and other associated services to the biotechnology and pharmaceutical companies. They assist life sciences companies in outsourcing non-core functions and gaining expertise across various clinical trial phases to accelerate new drug development. The complex regulatory environment and large investment required for novel drug research have prompted many drug makers to rely on CROs for specialized services. This has supported the expansion of CRO facilities and capabilities in the U.S.

Market Dynamics:

Key growth drivers for the U.S. contract research organization (CROs) market include rising research and development expenditure of pharmaceutical companies, increasing clinical trial volume & complexity, and focus on core competencies through outsourcing. However, pricing pressures due to intense competition and shorter drug development timelines pose significant challenges. Meanwhile, the shift towards niche/orphan drug development and adoption of new technologies like artificial intelligence offer substantial opportunities. Higher demand for specialized expertise in areas like oncology, rare disease, and cell & gene therapy are likely to further drive market revenues.

Key Features of the Study:

This report provides an in-depth analysis of the U.S. contract research organization (CROs) market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the U.S. contract research organization (CROs) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study IQVIA INC., ICON plc,Labcorp, Syneos Health, PROMETRIKA, LLC., Premier Research, Caidya,Charles River Laboratories, Inc., Parexel International Corporation, Medpace, Inc., WuXi AppTec, Courante Oncology, EPS Corporation, Worldwide Clinical Trials, and Tigermed.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The U.S. contract research organization (CROs) market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. contract research organization (CROs) market.

Detailed Segmentation-

By Service Type:
- Drug Discovery
- Preclinical studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical coding and writing
- Monitoring
- Clinical Data Management
- Others
By Therapeutic Application:
- Oncology
- Cardiovascular Diseases
- Central Nervous System Diseases
- Infectious Diseases
- Immunological Disorders
- Respiratory Disorders
- Others
By Size of CROs:
- Small Size (Less than 100 employees)
- Medium Size (100-500 employees)
- Large Size (More than 500 employees)
Company Profiles:
- IQVIA INC.
- ICON plc
- Labcorp
- Syneos Health
- PROMETRIKA, LLC.
- Premier Research
- Caidya
- Charles River Laboratories, Inc.
- Parexel International Corporation
- Medpace, Inc.
- WuXi AppTec
- Courante Oncology
- EPS Corporation
- Worldwide Clinical Trials
- Tigermed

Product Code: CMI3179

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By Size of CROs
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Regulatory Scenario
Technological Advancements
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. U.S. Contract Research Organization (CROs) Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. U.S. Contract Research Organization (CROs) Market, By Service Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Preclinical studies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Early Phase I - IIa
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Phase IIa - III
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Phase IIIb - IV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Medical coding and writing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Clinical Data Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. U.S. Contract Research Organization (CROs) Market, By Therapeutic Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Central Nervous System Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunological Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Respiratory Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. U.S. Contract Research Organization (CROs) Market, By Size of CROs, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Small Size (Less than 100 employees)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Medium Size (100-500 employees)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Large Size (More than 500 employees)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Competitive Landscape

Company Profiles
- IQVIA INC.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- ICON plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Labcorp
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Syneos Health
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PROMETRIKA, LLC.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Premier Research
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Caidya
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Charles River Laboratories, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Parexel International Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Medpace, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- WuXi AppTec
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Courante Oncology
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- EPS Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Worldwide Clinical Trials
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Tigermed
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies

9. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us and Sales Contact